STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Clinical trials for STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo shows promise in early sarcoma trial
Disease control OngoingThis early-phase study tests whether combining two immunotherapy drugs—nivolumab (given intravenously) and BO-112 (injected directly into the tumor)—before surgery is safe and effective for people with soft tissue sarcoma that can be surgically removed. About 14 adults with vario…
Matched conditions: STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Shorter radiation before sarcoma surgery: fewer days, same goal?
Disease control OngoingThis study tests a shorter, higher-dose radiation treatment given before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal is to see if this approach affects wound healing after surgery. About 120 adults with localized, removable sarcoma will take part.
Matched conditions: STAGE I SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC